Skip to main content

9 Result(s)

within J Bahlo Remove this filter English Remove this filter

and

  1. No Access

    Article

    Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials

    Richter transformation (RT) is defined as development of aggressive lymphoma in patients (pts) with CLL. The incidence rates of RT among pts with CLL range from 2 to 10%. The aim of this analysis is to report ...

    O. Al-Sawaf, S. Robrecht, J. Bahlo, A. M. Fink, P. Cramer, J. v Tresckow… in Leukemia (2021)

  2. No Access

    Article

    Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia

    M. Fürstenau, J. Bahlo, A. M. Fink, E. Lange, P. Dreger, M. Dreyling, G. Hess… in Leukemia (2020)

  3. Article

    Open Access

    Lamin B1 regulates somatic mutations and progression of B-cell malignancies

    Somatic hypermutation (SHM) is a pivotal process in adaptive immunity that occurs in the germinal centre and allows B cells to change their primary DNA sequence and diversify their antigen receptors. Here, we ...

    T Klymenko, J Bloehdorn, J Bahlo, S Robrecht, G Akylzhanova, K Cox… in Leukemia (2018)

    Download PDF (2558 KB) View Article

  4. No Access

    Article

    Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

    M A Hoechstetter, R Busch, B Eichhorst, A Bühler, D Winkler, M J Eckart… in Leukemia (2017)

  5. No Access

    Article

    Rare germline variants in ATM are associated with chronic lymphocytic leukemia

    G Tiao, M R Improgo, S Kasar, W Poh, A Kamburov, D-A Landau, E Tausch… in Leukemia (2017)

  6. No Access

    Article

    Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group

    O Al-Sawaf, S Robrecht, J Bahlo, A M Fink, P Cramer, J von Tresckow, C Maurer… in Leukemia (2017)

  7. No Access

    Article

    Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial

    J Edelmann, E Tausch, D A Landau, S Robrecht, J Bahlo, K Fischer, A M Fink… in Leukemia (2017)

  8. No Access

    Article

    Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL

    This study aimed to assess the frequency of and the contributing factors for second primary malignancies (SPMs) and Richter’s transformations (RTs) following first-line treatment of chronic lymphocytic leukemi...

    C Maurer, P Langerbeins, J Bahlo, P Cramer, A M Fink, N Pflug, A Engelke… in Leukemia (2016)

  9. No Access

    Article

    Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia

    T Elter, R James, R Busch, D Winkler, M Ritgen, S Böttcher, C Kahl, W Gassmann… in Leukemia (2012)